3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Congenital Abnormalities
2
Carcinoma, Renal Cell
2
Uveal Melanoma
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Osteosarcoma
1
Optic Nerve Glioma
1
Oligodendroglioma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms, Neuroepithelial
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Interventions
Cyclophosphamide
48
fludarabine phosphate
45
fludarabine
38
Whole-Body Irradiation
38
Mycophenolic Acid
37
Imatinib Mesylate
36
nilotinib
34
Tacrolimus
30
Busulfan
23
Cyclosporine
18
Melphalan
17
Granulocyte Colony-Stimulating Factor
17
Dasatinib
17
thymoglobulin
16
Methotrexate
16
Thiotepa
15
Peripheral Blood Stem Cell Transplantation
15
Antilymphocyte Serum
15
bosutinib
13
Filgrastim
13
Stem Cell Transplantation
11
sargramostim
8
ponatinib
8
Cytarabine
8
Cyclosporins
8
Cord Blood Stem Cell Transplantation
8
Clofarabine
8
Sirolimus
7
Rituximab
7
plerixafor
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
Immunologic Techniques
×
Clear all
No trials found.